Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline-Reference-Cited by-同舟云学术

Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline

Published:2008 Issue:6 Volume:47 Page:503-509
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Minami Shuwa¹²,Kawayama Tomotaka¹,Ichiki Masao¹²,Nishiyama Mamoru¹³,Sueyasu Yoshiko¹⁴,Gohara Rumi¹⁵,Kinoshita Masaharu¹⁶,Koga Hideyuki¹²,Iwanaga Tomoaki¹,Aizawa Hisamichi¹

Affiliation:

1. Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine

2. National Hospital Organization Kyushu Medical Center

3. Social Insurance Tagawa Hospital

4. Chikugo City Hospital

5. Yame General Hospital

6. Nagata Hospital

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/47/6/47_6_503/_pdf

Reference21 articles.

1. 1. National Heart Lung and Blood Institute/World Health Organization. Global initiative for chronic obstructive lung disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2005) http://www.goldcopd.org/ Accessed June 2006.

2. The pharmacokinetics of the ?2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation

3. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function

4. Efficacy of Salmeterol Xinafoate in the Treatment of COPD

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of transdermal tulobuterol on dyspnea and respiratory function during exercise in patients with chronic obstructive pulmonary disease;J THORAC DIS;2015

2. Cough variant and cough-predominant asthma are major causes of persistent cough: a multicenter study in Japan;Journal of Asthma;2013-08-20

3. Transdermal Tulobuterol Patch, a Long-Acting β2-Agonist;Allergology International;2012